Christine Borowski - Dec 29, 2023 Form 3 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Director
Signature
/s/ Mutya Harsch, Attorney-in-Fact for Christine Borowski
Stock symbol
VYNE
Transactions as of
Dec 29, 2023
Transactions value $
$0
Form type
3
Date filed
1/3/2024, 05:01 PM
Next filing
Jan 3, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24.1 - Power of Attorney